Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System

• Päätekijät: Michele Fusaroli (Tekijä), Emanuel Raschi (Tekijä), Milo Gatti (Tekijä), Fabrizio De Ponti (Tekijä), Elisabetta Poluzzi (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2021-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Introduction: The analysis of pharmacovigilance databases is crucial for the safety profiling of new and repurposed drugs, especially in the COVID-19 era. Traditional pharmacovigilance analyses-based on disproportionality approaches-cannot usually account for the complexity of spontaneous reports of...